ECM Skin Booster
第五代胶原水光
Dermal health is the core of a firm, resilient complexion. The Human Acellular Dermal Matrix (hADM) Extracellular Matrix Injectable, often referred to as an ECM Skin Booster, is a medical procedure designed to directly support the skin’s structural scaffolding. Derived from natural human acellular dermal matrix (hADM), this micro-particulate injectable delivers native structural proteins—including native collagen and elastin fragments—directly into the dermal layer to replenish the extracellular matrix (ECM).
How It Works: Direct ECM Supplementation
This treatment uses a unique approach focused on direct structural supplementation rather than indirect stimulation.
-
Extracellular Matrix (ECM) Replacement: The injectable physically places native dermal proteins into the dermis.
-
Direct Scaffolding Support: Unlike traditional injectables that rely only on hydration or biochemical triggers, this modality directly supplements the dermal matrix with foundational building blocks to reinforce the skin structure.
Comparing hADM/ECM with Other Similar Modalities
hADM Extracellular Matrix Injectable (ECM Booster):
-
Main Action: Direct delivery of biological matrix proteins (native collagen, elastin fragments) into the dermis.
-
Clinical Goal: Imparts structural dermal support, refines surface texture, and improves skin density.
-
Tactile Result: Restores structural firmness and skin thickness.
Traditional Hyaluronic Acid (HA) Dermal Boosters:
-
Main Action: Intradermal placement of water-binding hyaluronic acid micro-droplets.
-
Clinical Goal: Temporarily increases tissue hydration and smooths fine surface dryness lines.
-
Tactile Result: Imparts temporary dewy smoothness.
Collagen-Stimulating Biostimulatory Injectables:
-
Main Action: Non-HA particles that encourage secondary tissue production over time.
-
Clinical Goal: Supports long-term density improvement by promoting structural collagen production.
-
Tactile Result: Provides gradual, deep structural support.
Volumizing Dermal Fillers:
-
Main Action: Deep placement of cross-linked hyaluronic acid or other gels to re-contour or lift tissues.
-
Clinical Goal: Replaces lost fat or bone volume and contours facial shape.
-
Tactile Result: Provides immediate localized volume projection.
Variations in Particle Formulation
Different formulations of the hADM/ECM injectable are selected based on specific dermal needs and technique:
-
Micro-Particle Formulation (~75 μm): Offers smaller particle dimensions for smoother, more superficial dermal delivery.
-
Macro-Particle Formulation (~100 μm): Features larger particle dimensions suitable for deeper dermal tissue support.
Who is This Suitable For?
Following a medical consultation, an evaluation for hADM/ECM Extracellular Matrix Injectable may be considered for individuals:
-
Seeking structural support for thin or lax skin due to dermal depletion.
-
Wanting to manage the appearance of enlarged pores or uneven texture.
-
Seeking improved skin resilience and density.
Observed Physiological Responses
Data from human application tests across multiple skin parameters have demonstrated objective tissue responses to direct hADM/ECM supplementation, reinforcing its role in supporting structural skin quality:
-
Increased Dermal Density: Objective improvements observed in tissue density and structural framework.
-
Surface Refinement: Data supports concurrent refinement in texture density and a reduction in surface roughness.
-
Elasticity Maintenance: Helps maintain existing structural elasticity over extended periods.
Outcome guarantees are not provided. Final results depend on individual physiological responses.
